journal article·2021-04Open access

Microbiota‐Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling

Lucia Boeri, Simone Perottoni, Luca Izzo, Carmen Giordano, Diego Albani

Advanced Healthcare Materials· Volume 10· Issue 7

Abstract

Abstract Human microbiota communicates with its host by secreting signaling metabolites, enzymes, or structural components. Its homeostasis strongly influences the modulation of human tissue barriers and immune system. Dysbiosis‐induced peripheral immunity response can propagate bacterial and pro‐inflammatory signals to the whole body, including the brain. This immune‐mediated communication may contribute to several neurodegenerative disorders, as Alzheimer's disease. In fact, neurodegeneration is associated with dysbiosis and neuroinflammation. The interplay between the microbial communities and the brain is complex and bidirectional, and a great deal of interest is emerging to define the exact mechanisms. This review focuses on microbiota‐immunity‐central nervous system (CNS) communication and shows how gut and oral microbiota populations trigger immune cells, propagating inflammation from the periphery to the cerebral parenchyma, thus contributing to the onset and progression of neurodegeneration. Moreover, an overview of the technological challenges with in vitro modeling of the microbiota‐immunity‐CNS axis, offering interesting technological hints about the most advanced solutions and current technologies is provided.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Vagus Nerve Stimulation Research · Tryptophan and brain disorders · Gut microbiota and health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Materials and Chemical Engineering “Giulio Natta” Politecnico di Milano Piazza Leonardo da Vinci 32 Milan 20133 Italy

Department of Neuroscience Istituto di Ricerche Farmacologiche Mario Negri IRCCS via Mario Negri 2 Milan 20156 Italy

Funding

European Research Council · H2020 European Research Council

References (100+)

Show source-provided references
1. 10.1007/s00203-020-01931-x10.1007/s00203-020-01931-x ↗
2. 10.1016/j.micpath.2019.10369610.1016/j.micpath.2019.103696 ↗
3. 10.1038/s41579-018-0089-x10.1038/s41579-018-0089-x ↗
4. 10.3390/nu1011176510.3390/nu10111765 ↗
5. 10.1038/nature2517710.1038/nature25177 ↗
6. 10.3390/bioengineering604009110.3390/bioengineering6040091 ↗
7. 10.1111/imm.1253810.1111/imm.12538 ↗
8. 10.1164/rccm.201010-1574OC10.1164/rccm.201010-1574OC ↗
9. 10.1016/j.cell.2014.03.01110.1016/j.cell.2014.03.011 ↗
10. 10.1111/cei.1315810.1111/cei.13158 ↗
11. 10.1016/j.ccell.2018.03.01510.1016/j.ccell.2018.03.015 ↗
12. 10.1080/20002297.2018.156340510.1080/20002297.2018.1563405 ↗
13. 10.3390/nu1006070810.3390/nu10060708 ↗
14. 10.3988/jcn.2016.12.2.14710.3988/jcn.2016.12.2.147 ↗
15. 10.1016/j.dadm.2016.01.00110.1016/j.dadm.2016.01.001 ↗
16. 10.3389/fnins.2017.0015110.3389/fnins.2017.00151 ↗
17. 10.3389/fcimb.2020.0029710.3389/fcimb.2020.00297 ↗
18. 10.3389/fnins.2018.0004910.3389/fnins.2018.00049 ↗
19. 10.1016/j.neuint.2018.08.00510.1016/j.neuint.2018.08.005 ↗
20. 10.3748/wjg.v21.i29.878710.3748/wjg.v21.i29.8787 ↗
21. 10.1126/sciadv.aau333310.1126/sciadv.aau3333 ↗
22. 10.3389/fimmu.2019.0193710.3389/fimmu.2019.01937 ↗
23. 10.3389/fcimb.2017.0031810.3389/fcimb.2017.00318 ↗
24. 10.1080/20002297.2018.148774210.1080/20002297.2018.1487742 ↗
25. 10.1016/j.immuni.2017.04.00810.1016/j.immuni.2017.04.008 ↗
26. 10.1186/s40779-017-0122-910.1186/s40779-017-0122-9 ↗
27. 10.1016/B978-1-4377-0774-8.10031-410.1016/B978-1-4377-0774-8.10031-4 ↗
28. 10.1016/j.it.2018.04.00210.1016/j.it.2018.04.002 ↗
29. 10.1038/nri.2016.4210.1038/nri.2016.42 ↗
30. 10.1080/19490976.2015.105697310.1080/19490976.2015.1056973 ↗
31. 10.1016/j.cell.2004.05.00110.1016/j.cell.2004.05.001 ↗
32. 10.1111/nyas.1366010.1111/nyas.13660 ↗
33. 10.3390/microorganisms708027110.3390/microorganisms7080271 ↗
34. 10.1080/16512235.2017.135388110.1080/16512235.2017.1353881 ↗
35. 10.1016/j.coi.2017.08.01110.1016/j.coi.2017.08.011 ↗
36. 10.1096/fj.12-22386710.1096/fj.12-223867 ↗
37. 10.1016/j.rmed.2011.09.00710.1016/j.rmed.2011.09.007 ↗
38. 10.1016/S1348-8643(16)30024-610.1016/S1348-8643(16)30024-6 ↗
39. 10.1007/s10047-014-0798-510.1007/s10047-014-0798-5 ↗
40. 10.1111/joim.1247610.1111/joim.12476 ↗
41. 10.1074/jbc.M114.60205210.1074/jbc.M114.602052 ↗
42. 10.1371/journal.pone.005849610.1371/journal.pone.0058496 ↗
43. 10.4049/jimmunol.100325210.4049/jimmunol.1003252 ↗
44. 10.3389/fcimb.2017.0035910.3389/fcimb.2017.00359 ↗
45. 10.1016/j.brainres.2018.03.02710.1016/j.brainres.2018.03.027 ↗
46. 10.1016/j.coph.2019.08.00110.1016/j.coph.2019.08.001 ↗
47. 10.1172/JCI7836110.1172/JCI78361 ↗
48. 10.1093/bja/aep03710.1093/bja/aep037 ↗
49. 10.1016/S0361-9230(97)00020-810.1016/S0361-9230(97)00020-8 ↗
50. 10.1038/nature0132110.1038/nature01321 ↗
51. 10.3390/molecules2421399210.3390/molecules24213992 ↗
52. 10.1186/s40168-018-0439-y10.1186/s40168-018-0439-y ↗
53. 10.1016/j.nbd.2019.10471410.1016/j.nbd.2019.104714 ↗
54. 10.1016/j.bbi.2017.06.01710.1016/j.bbi.2017.06.017 ↗
55. 10.3390/cells802013510.3390/cells8020135 ↗
56. 10.1016/j.ejphar.2017.09.04410.1016/j.ejphar.2017.09.044 ↗
57. 10.1182/blood-2013-02-48621710.1182/blood-2013-02-486217 ↗
58. 10.1371/journal.ppat.100261910.1371/journal.ppat.1002619 ↗
59. 10.1038/ncomms202310.1038/ncomms2023 ↗
60. 10.1046/j.1440-1746.2003.03032.x10.1046/j.1440-1746.2003.03032.x ↗
61. 10.1016/j.mehy.2016.11.01210.1016/j.mehy.2016.11.012 ↗
62. 10.1111/j.1348-0421.1999.tb02438.x10.1111/j.1348-0421.1999.tb02438.x ↗
63. 10.1152/ajpgi.00469.200710.1152/ajpgi.00469.2007 ↗
64. 10.1002/cm.2054710.1002/cm.20547 ↗
65. 10.4161/21688370.2014.97717610.4161/21688370.2014.977176 ↗
66. 10.1091/mbc.E04-12-108910.1091/mbc.E04-12-1089 ↗
67. 10.1242/jcs.0291510.1242/jcs.02915 ↗
68. 10.1074/jbc.M109.06480810.1074/jbc.M109.064808 ↗
69. 10.1074/jbc.M90525119910.1074/jbc.M905251199 ↗
70. 10.1074/jbc.M50633820010.1074/jbc.M506338200 ↗
71. 10.1152/ajpgi.00186.201210.1152/ajpgi.00186.2012 ↗
72. 10.1053/j.semperi.2008.01.00210.1053/j.semperi.2008.01.002 ↗
73. 10.3390/ijms1909269310.3390/ijms19092693 ↗
74. 10.3390/proteomes602001710.3390/proteomes6020017 ↗
75. 10.1136/svn-2018-00019810.1136/svn-2018-000198 ↗
76. 10.1002/dneu.2095410.1002/dneu.20954 ↗
77. 10.1016/j.yexcr.2015.05.01310.1016/j.yexcr.2015.05.013 ↗
78. 10.1007/s12035-014-9054-510.1007/s12035-014-9054-5 ↗
79. 10.1242/dev.12930410.1242/dev.129304 ↗
80. 10.1111/j.1600-065X.2009.00782.x10.1111/j.1600-065X.2009.00782.x ↗
81. 10.1186/1742-2094-8-2510.1186/1742-2094-8-25 ↗
82. 10.3389/fncel.2019.0005610.3389/fncel.2019.00056 ↗
83. 10.12659/MSMBR.89309310.12659/MSMBR.893093 ↗
84. 10.1016/j.bbadis.2016.12.01610.1016/j.bbadis.2016.12.016 ↗
85. 10.1111/imm.1217010.1111/imm.12170 ↗
86. 10.1002/wmts.4610.1002/wmts.46 ↗
87. 10.5056/jnm1808710.5056/jnm18087 ↗
88. 10.1212/WNL.000000000000339110.1212/WNL.0000000000003391 ↗
89. 10.3389/fnmol.2019.0025810.3389/fnmol.2019.00258 ↗
90. 10.1016/j.jmb.2019.02.00410.1016/j.jmb.2019.02.004 ↗
91. 10.1016/j.expneurol.2014.05.01510.1016/j.expneurol.2014.05.015 ↗
92. 10.1007/s00401-011-0833-z10.1007/s00401-011-0833-z ↗
93. 10.1016/S0306-4522(02)00230-010.1016/S0306-4522(02)00230-0 ↗
94. 10.3390/ijms2103111510.3390/ijms21031115 ↗
95. 10.1186/1742-2094-5-5110.1186/1742-2094-5-51 ↗
96. 10.1155/2018/603917110.1155/2018/6039171 ↗
97. 10.1186/s40478-014-0142-610.1186/s40478-014-0142-6 ↗
98. 10.1172/JCI6448410.1172/JCI64484 ↗
99. 10.3389/fnins.2019.0036910.3389/fnins.2019.00369 ↗
100. 10.1016/j.cell.2016.11.01810.1016/j.cell.2016.11.018 ↗